tbuckley/cabot-search huggingface dataset:
IgE food sensitization and self-reported symptoms in a school-aged cohort from Honduras
Authors: Charlene Dunaway Altamirano, Alvaro Mayorga Sirera, Kevin Barahona, David Aguilar-Andino, Kathie Hernandez, Alan Montalvo Nuñez, Carlos Caceres Reynaud, Mario Valeriano Lanza, Dylan Maldonado, Lisa Workman, Michael Nelson, Thomas Platts-Mills, Jeffrey Wilson
Journal: Journal of Allergy and Clinical Immunology (2024)
Enhancing Angioedema Patient Care: Unveiling Underutilization and Barriers in the Implementation of Patient-Reported Outcome Measurements
Authors: Ivan Cherrez Ojeda, Marcus Maurer, Jean Bousquet, Ana Gimenez-Arnau, Kiran Godse, Dorota Krasowska, Karla Robles-Velasco, Pavel Kolkhir, Sergey Tkachenko, Natasa Teovska Mitrevska, Marta Kolacinska-Flont, Izabela Kuprys-Lipinska, Joanna Molinska, Alicja Kasperska-Zajac, Magdalena Zajac, Mateusz Zamlynski, Florin Mihaltan, Anna Zalewska-Janowska, Katarzyna Tomaszewska, Mona Al-Ahmad, Maryam Ali Al-Nesf, Tayseer Ibrahim, David Pesqué, Monica Rodriguez-Gonzalez, Guillermo Hideo Wakida-Kuzunoki, German Ramon, Gonzalo Ramon, Sophia Neisinger, Hanna Bonnekoh, Maia Rukhadze, Ruxandra Ulmeanu, Maryam Khoshkhui, Marco Faytong-Haro, Daria Fomina, Michael Rudenko, Moshe Ben-shoshan, Desiree Larenas Linnemann, Violeta Kvedariene, Mitja Košnik, Torsten Zuberbier, Rabia Oztas Kara, Chrystopherson Gengyny Caballero López, Roberta Criado, Qiang Liu, Nelson Rosario
Journal: Journal of Allergy and Clinical Immunology (2024)
Management of severe chronic spontaneous urticaria with omalizumab
Authors: Laura Zubiaga Fernandez, Julia Rodriguez de Guzman Cejudo, Joan Bartra, Marta Ferrer, Maria Torres Jaen, Almudena Testera Montes, Carmen Rondon Segovia, Natalia Perez Sanchez, Ibon Eguiluz
Journal: Journal of Allergy and Clinical Immunology (2024)
Risk Stratification of Food Allergy Patients: Results from the International, Cross-sectional Prevalence and Severity Study of Pediatric and Adult IgE-Mediated Food Allergies (ASSESS FA)
Authors: Alessandro Fiocchi, Jessica Marvel, Tarek Mnif, Mira Hleyhel, Perrine Le Calve, Alissar Moussallem, Bastien Vincent, Paolo Tassinari, Margitta Worm, Ruchi Gupta
Journal: Journal of Allergy and Clinical Immunology (2024)
Briquilimab, An Anti-CD117 Antibody, Prevents Passive Systemic Anaphylaxis In Mice Expressing Chimeric Human And Mouse CD117 Through Mast Cell Depletion
Authors: Charles Chang, Ajay Sharma, Andrew Wells, Revati Nerkar, Karl Meneses, Hye-Sook Kwon, Wendy Pang
Journal: Journal of Allergy and Clinical Immunology (2024)
Pharmacokinetic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy Adults
Authors: Matthew Greenhawt, David Bernstein, Michael Blaiss, Lawrence Dubuske, David Fleischer, Jay Lieberman, John Oppenheimer, David Dworaczyk
Journal: Journal of Allergy and Clinical Immunology (2024)
Phase 2 Open-Label Extension Study With Donidalorsen in Patients With Hereditary Angioedema: 1 Year Versus 2 Years
Authors: Raffi Tachdjian, Laura Bordone, Steve Dorow, Danny Cohn, Eugene Schneider, Yiwen Deng, Kenneth Newman, Veronica Alexander, Marc Riedl
Journal: Journal of Allergy and Clinical Immunology (2024)
Improved Lung Function is Associated With Better Asthma Control in Children Aged 6 to 11 Years With Moderate-To-Severe Type 2 Asthma: A Post Hoc Analysis of VOYAGE
Authors: Leonard Bacharier, Sharon Dell, Ines de Mir-Messa, Giorgio Piacentini, Eckard Hamelmann, Jérôme Msihid, Rebecca Gall, Olivier Ledanois, Zhixiao Wang, Wei-Han Cheng, Harry Sacks, Juby Jacob-Nara, Paul Rowe, Yamo Deniz
Journal: Journal of Allergy and Clinical Immunology (2024)
Common Variable Immunodeficiency with Human Herpes Virus 6 Reactivation in Ukrainian Secondary Hypersensitivity Vasculitis Patients
Authors: Kh. Lishchuk-Yakymovych, V. Chopyak, R. Pukalyak, O. Synenkyy, N. Mazepa, Lawrence Dubuske
Journal: Journal of Allergy and Clinical Immunology (2024)
IL-4Rα Blockade Reduces Levels of IL-6 Family Cytokines including Oncostatin M (OSM) and IL-6 in Nasal Fluid of Patients with Aspirin Exacerbated Respiratory Disease (AERD) and Nasal Polyps
Authors: Chongjia Chen, Kathleen Buchheit, Barbara Balestrieri, Daniel Dwyer, Aaqib Sohail, Laura Cho, Tahereh Derakhshan, Jillian Bensko, Alanna McGill, Tessa Ryan, Carolyn Baloh, Tanya Laidlaw
Journal: Journal of Allergy and Clinical Immunology (2024)
New diagnosis of Eosinophilic Esophagitis (EoE) in patients undergoing Oral immunotherapy (OIT): a retrospective review of real-world Multi-foods or single-food OIT in 788 children and young adults
Authors: Jessica Frangiosa, Luca Diem, Elizabeth Hanna, Megan Lewis, Kristen Corrigan, Michele Shuker, Rahul Datta, Laura Gober, Katie Kennedy, Ashley Kazatsky, Elisa Ochfeld, Jillian Buonanno, Caroline Sanborne, Christine McManamon, Jonathan Spergel, Amanda Muir, Kim Nguyen, Antonella Cianferoni
Journal: Journal of Allergy and Clinical Immunology (2024)
The Brazilian Registry for Hereditary Angioedema: insights from the first 283 Patients
Authors: Jose Lemos, Mariana Ferriani, Fernanda Nunes, Marina Dias, Pedro Giavina-Bianchi, Pérsio Roxo Júnior, Fernanda Minafra, Gabriela Dias, Faradiba Serpa, Fernanda Marcelino, jane Silva, Herberto Chong Neto, Rozana Gonçalves, Lucca Nogueira, Régis Campos, Joanemile De Figueiredo, Marcelo Aun, Ana Teixeira, Eliana Toledo, Iramirton Moreira, Solange Valle, Anne Camargo, Fabiane Lopes, Maria Zanetti, Orlando Trevisan Neto, Luana Maia, Fabiola Traina, Adriana Moreno, Maite Kolarik, Nelson Rosario, Caroline Guth, Davi Aragon, Luisa Karla Arruda, Anete Grumach
Journal: Journal of Allergy and Clinical Immunology (2024)
Experience with Benralizumab in the severe asthma unit of Hospital Universitario Fundación Alcorcón, Spain
Authors: Maria de Los Angeles Gonzalez Labrador, Beatriz Gutierrez Argumosa, Andrea Morán Garrido, Natalia Gutierrez Albaladejo, Alicia Moncada Salinero, Miguel Angel Tejedor Alonso, Ana Gonzalez Moreno, Ana Rosado Ingelmo
Journal: Journal of Allergy and Clinical Immunology (2024)
Knowledge and satisfaction about the use of Patient Reported Outcomes Measures (PROMs) by patients with chronic urticaria
Authors: Ivan Cherrez Ojeda, Karla Robles-Velasco, Alicja Kasperska-Zajac, Kanokvalai Kulthanan, Phuwakorn Saengthong-aram, Umit Murat Sahiner, Ozge Soyer, Emek Kocaturk Goncu, Deniz İLGÜN GÜREL, Bulent Sekerel, Esen Özkaya, Elena Latysheva, Raisa Meshkova, Gabriela Dias, Jorge Sanchez Caraballo, Luis Escalante, Astrid Maldonado, Edgar Escalante, Maria Touriz, Oscar Calderon LLosa, Indrashis Podder, Iman Nasr, George Christoff, Belen Intriago, Marco Faytong-Haro, Chuda Rujitharanawong, Leena Chularojanamontri
Journal: Journal of Allergy and Clinical Immunology (2024)
The Temporal Trends of Peanut Anaphylaxis Rates in a Pediatric Emergency Department in Montreal, Canada, Following Early Peanut Introduction Guidelines
Authors: Derek Lanoue, Joshua Yu, Adhora Mir, Mohammed Kaouache, Adam Bretholz, Ann Clarke, Christine McCusker, Jennifer Protudjer, Moshe Ben-Shoshan
Journal: Journal of Allergy and Clinical Immunology (2024)
Indoor Allergen Exposure and Its Influence on Upper Respiratory Infections and Pulmonary Outcomes among Children with Asthma
Authors: Darlene Bhavnani, Sylvie Beaudenon-Huibregtse, Meghan Davis, Meredith McCormack, Corinne Keet, Susan Balcer-Whaley, Michelle Newman, Elizabeth Matsui
Journal: Journal of Allergy and Clinical Immunology (2024)
Reductions in Polypharmacy for Patients with Indolent Systemic Mastocytosis on Avapritinib
Authors: Cem Akin, Jason Gotlib, Ivan Alvarez-Twose, Deepti Radia, Tsewang Tashi, Cristina Bulai Livideanu, Vito Sabato, Hanneke Oude Elberink, Joseph Jurcic, Paul Van Daele, Andreas Reiter, Prithviraj Bose, Peter Vadas, Patrizia Bonadonna, Daniel DeAngelo, Karin Hartmann, Stephen Oh, Princess Ogbogu, Jocelyn Rice, Mehak Gulati, Ilda Bidollari, Kate Newberry, Hui-Min Lin, Mariana Castells
Journal: Journal of Allergy and Clinical Immunology (2024)
Targeting Infiltrating Lung Monocyte-Macrophages to Reduce Environmental Exposure-Induced Lung Disease
Authors: Grace Moravec, Aaron Schwab, Amy Nelson, Angela Gleason, Michael Duryee, Oliver Schanze, Debra Romberger, Todd Wyatt, Geoffrey Thiele, Ted Mikuls, Jill Poole
Journal: Journal of Allergy and Clinical Immunology (2024)
Blocking CD226 regulates ILC2 effector function and alleviates airway hyperreactivity
Authors: Yoshihiro Sakano, Kei Sakano, Benjamin Hurrell, Doumet Helou, Pedram Shafiei-Jahani, Mohammad Kazemi, Xin Li, Stephen Shen, Richard Barbers, Omid Akbari
Journal: Journal of Allergy and Clinical Immunology (2024)
Racial Difference in Shopping Habits of Food Allergic Individuals: FORWARD
Authors: Mark Wlodarski, Ruchi Gupta, Hemant Sharma, Mahboobeh Mahdavinia, Amal Assa'ad, Lucy Bilaver, Christopher Warren, Susan Fox, Linda Herbert, Pamela Newmark, Jialing Jiang, Megan Ullrich, Aame Andy-Nweye, Izeris Ortiz-Rodriguez
Journal: Journal of Allergy and Clinical Immunology (2024)
Do They Really Have A Drug Allergy? General Pediatricians Collaborate with Allergists to Delabel False Penicillin Allergies
Authors: Renée Crawford, Taylor Burton, Victoria Lorah, Harrison Van Dolah, Ian Kloehn, Jacob Phouthavong-Murphy, Alyssa Pianto, Jennifer Farabaugh, Christine Rukasin, Kristen Samaddar
Journal: Journal of Allergy and Clinical Immunology (2024)
Global distribution of physician-diagnosed adult-onset food allergy: results from the international, cross-sectional prevalence and severity study of pediatric and adult IgE-mediated food allergies (ASSESS FA)
Authors: Ruchi Gupta, Tarek Mnif, Suzanne Reed, Perrine Le Calve, Mira Hleyhel, Bastien Vincent, Jessica Marvel, Paolo Tassinari, Margitta Worm, Alessandro Fiocchi
Journal: Journal of Allergy and Clinical Immunology (2024)
Eosinophilia in a racially, socioeconomically, and geographically diverse cohort of patients with allergist-diagnosed food allergy
Authors: Christopher Warren, Amal Assa'ad, Caglar Onal, Lucy Bilaver, Megan Ullrich, Jack Ringle, Susan Fox, Jialing Jiang, Mahboobeh Mahdavinia, Hemant Sharma, Ruchi Gupta
Journal: Journal of Allergy and Clinical Immunology (2024)
Lower Socioeconomic Status Associated with Increased Food Allergy Reaction Burden Longitudinally
Authors: Neil Thivalapill, Lucy Bilaver, Jialing Jiang, Christopher Warren, Lihui Zhao, Linda Herbert, Susan Fox, Pamela Newmark, Aame Andy-Nweye, Izeris Ortiz-Rodriguez, Megan Ullrich, Amal Assa'ad, Mahboobeh Mahdavinia, Hemant Sharma, Ruchi Gupta
Journal: Journal of Allergy and Clinical Immunology (2024)
Burden Of Angioedema Among Patients With Chronic Spontaneous Urticaria In The United States.
Authors: Maria-Magdalena Balp, Dhaval Patil, Jonathan Rodrigues, Ravneet Kohli, Kathryn Krupsky, Bridget Balkaran, Shaloo Gupta, Brian Williams, Weily Soong
Journal: Journal of Allergy and Clinical Immunology (2024)
Association of Asthma Specialty Care and Adverse Outcomes for Children Enrolled in the Arkansas Medicaid Program
Authors: Melanie Boyd, Erhan Ararat, Clare Brown, Arina Eyimina, Anthony Goudie, Mandana Rezaeiahari, J. Mick Tilford, Akilah Jefferson, Tamara Perry
Journal: Journal of Allergy and Clinical Immunology (2024)
European Respiratory Society statement on novel nicotine and tobacco products, their role in tobacco control and “harm reduction”
Authors: Daniel Tzu-Hsuan Chen, Jonathan Grigg, Filippos T. Filippidis
Journal: European Respiratory Journal (2024)

<h3>Tweetable abstract</h3> <b>The ERS Tobacco Control Committee finds lack of evidence supporting the tobacco industry9s "harm reduction" claims. All nicotine products remain harmful and addictive. It is vital to reduce tobacco use and protect youth from addiction to novel products.</b>https://bit.ly/3Ovm98C
Dupilumab Improves Skin Lipid Barrier in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis
Authors: Irina Bronova, Evgeny Berdyshev, Elena Goleva, Simon Danby, Anna Sofia Bronoff, Brittany Richers, Shannon Garcia, Marco Ramirez Gama, Patricia Taylor, Joseph Zahn, Inoncent Agueusop, Shantanu Bafna, Mark Boguniewicz, Peck Ong, Annie Zhang, Michael Cork, Donald Leung
Journal: Journal of Allergy and Clinical Immunology (2024)
<i>Phocaeicola vulgatus</i> alleviates diet-induced metabolic dysfunction-associated steatotic liver disease progression by downregulating histone acetylation level via 3-HPAA
Authors: Shengxi Jin, Peng Chen, Jing Yang, Duguang Li, Xiaolong Liu, Yiyin Zhang, Qiming Xia, Yiling Li, Guoqiao Chen, Yixuan Li, Yifan Tong, Weihua Yu, Xiaoxiao Fan, Hui Lin
Journal: Gut Microbes (2024)

Diet-induced metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent metabolic disorder with limited effective interventions available. A novel approach to address this issue is through gut microbiota-based therapy. In our study, we utilized multi-omics analysis to identify Phocaeicola vulgatus (P. vulgatus) as a potential probiotic for the treatment of MASLD. Our findings from murine models clearly illustrate that the supplementation of P. vulgatus mitigates the development of MASLD. This beneficial effect is partly attributed to the metabolite 3-Hydroxyphenylacetic acid (3-HPAA) produced by P. vulgatus, which reduces the acetylation levels of H3K27 and downregulates the transcription of Squalene Epoxidase (SQLE), a rate-limiting enzyme in steroid biosynthesis that promotes lipid accumulation in liver cells. This study underscores the significant role of P. vulgatus in the development of MASLD and the critical importance of its metabolite 3-HPAA in regulating lipid homeostasis. These findings offer a promising avenue for early intervention therapy in the context of MASLD.
High BMI as risk factor in mastectomy in transmasculine individuals: a retrospective matched case-control study
Authors: Wouter B. van der Sluis, Naomi van Hout, Mark-Bram Bouman
Journal: International Journal of Transgender Health (2024)

Introduction: Obesity as a risk factor in gender-affirming surgery is a hot topic. Though obesity is considered a risk factor for certain surgical complications, BMI cutoffs may be a barrier to surgical care for transgender individuals. Material and methods: All transgender individuals that underwent gender-affirming mastectomy in our center were retrospectively identified from a departmental database. Every transgender individual with a BMI > 34kg/m2 was matched 1:1 to an individual with a BMI between 18 and 25 kg/m2, based on: surgical technique, surgeon, smoking, resection weight (+/-150 grams), and comorbidity such as diabetes and cardiovascular diseases. A retrospective chart study was conducted, recording demographics, surgical characteristics, short- and long-term complications and reoperations. Complications were ordinally categorized according to the Clavien-Dindo (CD) classification. Outcomes of groups were compared. Results: A total of 53 individuals with BMI > 34 who underwent mastectomy were matched to 53 non-obese individuals according to the abovementioned matching criteria. A total of 44 (83%) non-obese individuals had a complication-free trajectory, versus 23 (43%, p < 0.01) in the obese group. Seroma occurred more frequently in obese individuals (n = 16 (30%) vs 2 (4%), p < 0.01). Looking at de CD rating system, obese individuals experienced more complications overall (p < 0.01). However, complications were mostly CD grade I or II. Secondary surgical chest contour corrections were performed in 9 (17%) obese versus 2 (4%) non-obese individuals. CD grade III complications occurred in 10 (18%) obese individuals and in 4 (8%) non-obese individuals. There were no grade CD grade IV or V complications. Conclusion: Mastectomy in individuals with obesity seems safe with regard to major complications. However, minor complications and revision surgery are significantly more frequently present in these individuals. Preoperative counseling should focus on the higher risk on complications and reoperations.
Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease
Authors: Bing Han, Daiyuan Tang, Xiaodan Lv, Junhua Fan, Shiquan Li, Hui Zhu, Jiatong Zhang, Shang Xu, Xiaofang Xu, Ziqian Huang, Zhixi Huang, Guangfu Lin, Lingling Zhan, Xiaoping Lv
Journal: Gut Microbes (2024)

Gut microbiota and related metabolites are both crucial factors that significantly influence how individuals with Crohn’s disease respond to immunotherapy. However, little is known about the interplay among gut microbiota, metabolites, Crohn’s disease, and the response to anti-α4β7-integrin in current studies. Our research utilized 2,4,6-trinitrobenzene sulfonic acid to induce colitis based on the humanized immune system mouse model and employed a combination of whole-genome shotgun metagenomics and non-targeted metabolomics to investigate immunotherapy responses. Additionally, clinical cases with Crohn’s disease initiating anti-α4β7-integrin therapy were evaluated comprehensively. Particularly, 16S-rDNA gene high-throughput sequencing and targeted bile acid metabolomics were conducted at weeks 0, 14, and 54. We found that anti-α4β7-integrin therapy has shown significant potential for mitigating disease phenotypes in remission-achieving colitis mice. Microbial profiles demonstrated that not only microbial composition but also microbially encoded metabolic pathways could predict immunotherapy responses. Metabonomic signatures revealed that bile acid metabolism alteration, especially elevated secondary bile acids, was a determinant of immunotherapy responses. Especially, the remission mice significantly enriched the proportion of the beneficial Lactobacillus and Clostridium genera, which were correlated with increased gastrointestinal levels of BAs involving lithocholic acid and deoxycholic acid. Moreover, most of the omics features observed in colitis mice were replicated in clinical cases. Notably, anti-α4β7 integrin provided sustained therapeutic benefits in clinical remitters during follow-up, and long-lasting remission was linked to persistent changes in the microbial-related bile acids. In conclusion, gut microbiota-mediated bile acid metabolism alteration could play a crucial role in regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease. Therefore, the identification of prognostic microbial signals facilitates the advancement of targeted probiotics that activate anti-inflammatory bile acid metabolic pathways, thereby improving immunotherapy responses. The integrated multi-omics established in our research provide valuable insights into potential mechanisms that impact treatment responses in complex diseases.
Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM)
Authors: Christopher P. Mill, Warren C. Fiskus, Courtney D. DiNardo, Patrick Reville, John A. Davis, Christine E. Birdwell, Kaberi Das, Hanxi Hou, Koichi Takahashi, Lauren Flores, Xinjia Ruan, Xiaoping Su, Sanam Loghavi, Joseph D. Khoury, Kapil N. Bhalla
Journal: Blood Cancer Journal (2024)

Abstract Germline, mono-allelic mutations in RUNX1 cause familial platelet disorder (RUNX1-FPD) that evolves into myeloid malignancy (FPD-MM): MDS or AML. FPD-MM commonly harbors co-mutations in the second RUNX1 allele and/or other epigenetic regulators. Here we utilized patient-derived (PD) FPD-MM cells and established the first FPD-MM AML cell line (GMR-AML1). GMR-AML1 cells exhibited active super-enhancers of MYB, MYC, BCL2 and CDK6, augmented expressions of c-Myc, c-Myb, EVI1 and PLK1 and surface markers of AML stem cells. In longitudinally studied bone marrow cells from a patient at FPD-MM vs RUNX1-FPD state, we confirmed increased chromatin accessibility and mRNA expressions of MYB, MECOM and BCL2 in FPD-MM cells. GMR-AML1 and PD FPD-MM cells were sensitive to homoharringtonine (HHT or omacetaxine) or mebendazole-induced lethality, associated with repression of c-Myc, EVI1, PLK1, CDK6 and MCL1. Co-treatment with MB and the PLK1 inhibitor volasertib exerted synergistic in vitro lethality in GMR-AML1 cells. In luciferase-expressing GMR-AML1 xenograft model, MB, omacetaxine or volasertib monotherapy, or co-treatment with MB and volasertib, significantly reduced AML burden and improved survival in the immune-depleted mice. These findings highlight the molecular features of FPD-MM progression and demonstrate HHT, MB and/or volasertib as effective agents against cellular models of FPD-MM.
Correction: ERK mediates interferon gamma-induced melanoma cell death
Authors: Ameya Champhekar, Rachel Heymans, Justin Saco, Guillem Turon Font, Cynthia Gonzalez, Anne Gao, John Pham, June Lee, Ryan Maryoung, Egmidio Medina, Katie M. Campbell, Daniel Karin, David Austin, Robert Damioseaux, Antoni Ribas
Journal: Molecular Cancer (2024)
From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research
Authors: Ayache Bouakaz, Jean Michel Escoffre
Journal: Advanced Drug Delivery Reviews (2024)

Ultrasound mediated drug delivery, a promising therapeutic modality, has evolved remarkably over the past three decades. Initially designed to enhance contrast in ultrasound imaging, microbubbles have emerged as a main vector for drug delivery, offering targeted therapy with minimized side effects. This review addresses the historical progression of this technology, emphasizing the pivotal role microbubbles play in augmenting drug extravasation and targeted delivery. We explore the complex mechanisms behind this technology, from stable and inertial cavitation to diverse acoustic phenomena, and their applications in medical fields. While the potential of ultrasound mediated drug delivery is undeniable, there are still challenges to overcome. Balancing therapeutic efficacy and safety and establishing standardized procedures are essential areas requiring attention. A multidisciplinary approach, gathering collaborations between researchers, engineers, and clinicians, is important for exploiting the full potential of this technology. In summary, this review highlights the potential of using ultrasound mediated drug delivery in improving patient care across various medical conditions.
Reaction History and the Development of Food Tolerance
Authors: Salma Alabduljabbar, Arabelle Abellard, Lucy Bilaver, Christopher Warren, Susan Fox, Jialing Jiang, Pamela Newmark, Amal Assa'ad, Hemant Sharma, Ruchi Gupta, Mahboobeh Mahdavinia
Journal: Journal of Allergy and Clinical Immunology (2024)
Skin Prick Test Using Autoclaved Peanut Extract Results in Decreased Wheal Sizes and is Associated with Lower Peanut-Specific IgE Levels in Allergic Patients
Authors: Casey Cohen, Diana Toscano Rivero, Eisha Ahmed, Wei Zhao, Danbing Ke, Duncan Lejtenyi, Liane Beaudette, Bertrand Jean-Claude, Moshe Ben-Shoshan, Bruce Mazer
Journal: Journal of Allergy and Clinical Immunology (2024)
“You get HIV because there is no hope” a rapid qualitative assessment of the HIV vulnerabilities of transgender women in three South African metros
Authors: Dhee Naidoo, Allanise Cloete, Donald Skinner, Helen Savva, Danielle Daniels, Zamakayise Kose, Malebo Gratitude Ramatshekgisa
Journal: International Journal of Transgender Health (2024)

Introduction Epidemiological data show that transgender women are disproportionately affected by Human Immunodeficiency Virus (HIV). Data in South Africa on the HIV vulnerabilities of transgender women are sparse. This paper qualitatively explores the structural, personal, and economic factors that contribute to making South African transgender women vulnerable to HIV and other sexually transmitted infections (STIs).
Comorbidities in patients with eosinophilic granulomatosis with polyangiitis and severe uncontrolled asthma: a retrospective analysis of US health insurance claims data
Authors: Paul Dolin, Danuta Kielar, Anat Shavit, Karina Keogh, Jennifer Rowell, Chris Edmonds, Juliana Meyers, Elizabeth Esterberg, Nham Tram, Stephanie Chen
Journal: Journal of Allergy and Clinical Immunology (2024)